Near-infrared spectroscopy for the detection of lipid core coronary plaques

Current Cardiovascular Imaging Reports

Volumn 2, Issue 4, 2009, Pages 307-315

  Sum, Stephen T ^a   Madden, Sean P ^b   Hendricks, Michael J ^b   Chartier, Steven J ^b   Muller, James E ^b  

^a INFRAREDX INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956636673     PISSN: 19419066     EISSN: 19419074     Source Type: Journal    
DOI: 10.1007/s12410-009-0036-3     Document Type: Article

References (53)

1. Lloyd-Jones D, Adams, R, Carnethon M, et al.: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119: 480-486.
2. Clarke MC, Figg N, Maguire JJ, et al.: Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006, 12: 1075-1080.
3. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340: 115-126.
4. Kagan A, Livsic AM, Sternby N, Vihert AM: Coronary-artery thrombosis and the acute attack of coronary heart-disease. Lancet 1968, 2: 1199-1200.
5. Goldstein JA: CT angiography: imaging anatomy to deduce coronary physiology. Catheter Cardiovasc Interv 2009, 73: 503-505.
6. Giroud D, Li JM, Urban P, et al.: Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992, 69: 729-732.
7. Gonzalo N, García-García HM, Ligthart J, et al.: Coronary plaque composition as assessed by greyscale intravascular ultrasound and radiofrequency spectral data analysis. Int J Cardiovasc Imaging 2008, 24: 811-818.
8. Schaar JA, Mastik F, Regar E, et al.: Current diagnostic modalities for vulnerable plaque detection. Curr Pharm Des 2007, 13: 995-1001.
9. Kips JG, Segers P, van Bortel LM: Identifying the vulnerable plaque: a review of invasive and non-invasive imaging modalities. Artery Res 2008, 2: 21-34.
10. Uchida Y, Nakamura F, Tomaru T, et al.: Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J 1995, 130: 195-203.
11. Ohtani T, Ueda Y, Mizote I, et al.: Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome detection of vulnerable patients by angioscopy. J Am Coll Cardiol 2006, 47: 2194-2200.
12. Ishibashi F, Aziz K, Abela G, Waxman S: Update on coronary angioscopy: review of a 20-year experience and potential application for detection of vulnerable plaque. J Interv Cardiol 2006, 19: 17-25.
13. Patel NA, Stamper DL, Brezinski ME: Review of the ability of optical coherence tomography to characterize plaque, including a comparison with intravascular ultrasound. Cardiovasc Intervent Radiol 2005, 28: 1-9.
14. Yabushita H, Bouma BE, Houser SL, et al.: Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002, 106: 1640-1645.
15. Tearney GJ, Yabushita H, Houser SL, et al.: Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003, 107: 113-119.
16. Yun SH, Tearney GJ, Vakoc BJ, et al.: Comprehensive volumetric optical microscopy in vivo. Nat Med 2007, 12: 1429-1433.
17. Lavine B, Workman J: Chemometrics. Anal Chem 2008, 80: 4519-4531.
18. Williams P, Norris K: Near-Infrared Technology in the Agriculture and Food Industries, edn 2. St. Paul, MN: American Association of Cereal Chemists Inc.; 2001.
19. Ciurczak EW, Drennen JK: Pharmaceutical and Medical Applications of Near-Infrared Spectroscopy. New York: Marcel Dekker; 2002.
20. Mendelson Y: Pulse oximetry: theory and applications for noninvasive monitoring. Clin Chem 1992, 38: 1601-1607.
21. Moreno PR, Muller JE: Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods. Curr Opin Cardiol 2002, 17: 638-647.
22. Lodder RA, Cassis L, Ciurczak EW: Arterial analysis with a novel near-IR fiber-optic probe. Spectroscopy 1990, 5: 12-17.
23. Cassis LA, Lodder RA: Near-IR imaging of atheromas in living arterial tissue. Anal Chem 1993, 65: 1247-1256.
24. Jaross W, Neumeister V, Lattke P, Schuh D: Determination of cholesterol in atherosclerotic plaques using near infrared diffuse reflection spectroscopy. Atherosclerosis 1999, 147: 327-337.
25. Neumeister V, Scheibe M, Lattke P, Jaross W: Determination of the cholesterol-collagen ratio of arterial atherosclerotic plaques using near infrared spectroscopy as a possible measure of plaque stability. Atherosclerosis 2002, 165: 251-257.
26. Moreno PR, Lodder RA, Purushothaman KR, et al.: Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation 2002, 105: 923-927.
27. Moreno PR, Ryan SE, Hopkins D: Identification of lipid-rich aortic atherosclerotic plaques in living rabbits with a near infrared spectroscopy catheter. J Am Coll Cardiol 2001, 37(Suppl A): 3A.
28. Lilledahl MB, Haugen OA, Barkost M, Svaasand LO: Reflection spectroscopy of atherosclerotic plaque. J Biomed Opt 2006, 11: 021005.
29. Dempsey RJ, Davis DG, Buice RG, Lodder RA: Biological and medical applications of near-infrared spectrometry. Appl Spectrosc 1996, 50: 18A-34A.
30. Wang J, Geng Y, Guo B, et al.: Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques. J Am Coll Cardiol 2002, 39: 1305-1313.
31. Moreno PR, Ryan SE, Hopkins D, et al.: Identification of lipid-rich plaques in human coronary artery autopsy specimens by near-infrared spectroscopy. J Am Coll Cardiol 2001, 37(Suppl A): 356A.
32. Marshik B, Tan H, Tang J, et al.: Discrimination of lipid-rich plaques in human aorta specimens with NIR spectroscopy through whole blood. Am J Cardiol 2002, 90(Suppl 6A): 129H.
33. Marshik B, Tan H, Tang J, et al.: Detection of thin-capped fibroatheromas in human aorta tissue with near infrared spectroscopy through blood. J Am Coll Cardiol 2003, 41(Suppl 1): 42.
34. Waxman S, Ishibashi F, Caplan JD: Rationale and use of near-infrared spectroscopy for detection of lipid-rich and vulnerable plaques. J Nucl Cardiol 2007, 14: 719-728.
35. Caplan JD, Waxman S, Nesto RW, Muller JE: Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques. J Am Coll Cardiol 2006, 47(Suppl C): C92-C96.
36. Waxman S, Tang J, Marshik BJ, et al.: In vivo detection of a coronary artificial target with a near infrared spectroscopy catheter. Am J Cardiol 2004, 94(Suppl 6A): 141E.
37. Waxman S, Khabbaz K, Connolly R, et al.: Intravascular imaging of atherosclerotic human coronaries in a porcine model: a feasibility study. Int J Cardiovasc Imaging 2008, 24: 37-44.
38. Gardner CM, Tan H, Hull EL, et al.: Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. J Am Coll Cardiol Imaging 2008, 1: 638-648.
39. Waxman S, Dixon SR, L'Allier P, et al.: In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results and exploratory analysis of the Spectroscopic Assessment of Coronary Lipid (SPECTACL) Multicenter Study. J Am Coll Cardiol Imaging 2009, 2: 858-868.
40. Waxman S: Near-infrared spectroscopy for plaque characterization. J Interv Cardiol 2008, 21: 452-458.
41. US Food and Drug Administration: Press announcements. Available at http://www. fda. gov/bbs/topics/news/2008/new01827. html. Accessed April 2009.
42. Maini B: Clinical coronary chemograms and lipid core containing coronary plaques. JACC Cardiovasc Imaging 2008, 1: 689-690.
43. Muller JE, Tawakol A, Kathiresan S, Narula J: New opportunities for identification and reduction of coronary risk treatment of vulnerable patients, arteries, and plaques. J Am Coll Cardiol 2006, 47(Suppl C): 2-6.
44. Dixon S: Detecting vulnerable plaque. CathLab Digest 2009, 17: 10.
45. Nissen SE: Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis. Am J Cardiol 2002, 89: 24B-31B.
46. Farb A, Burke AP, Kolodgie FD, Virmani R: Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003, 108: 1701-1706.
47. Joner M, Finn AV, Farb A, et al.: Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48: 193-202.
48. Oyabu J, Ueda Y, Ogasawara N, et al.: Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J 2006, 152: 1168-1174.
49. Finn AV, Nakazawa G, Ladich E, et al.: Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation?J Am Coll Cardiol Imaging 2008, 1: 1485-1488.
50. Nakazawa G, Finn AV, Joner M, et al.: Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008, 118: 1138-1145.
51. Kawaguchi R: Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. J Am Coll Cardiol 2007, 50: 1641-1646.
52. ClinicalTrials. Gov: An Observational Study of Cholesterol in Coronary Arteries (COLOR). Available at http://www. clinicaltrials. gov/ct2/show/NCT00831116. Accessed April 2009.
53. Sacks FM, Rudel LL, Conner A, et al.: Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo. J Lipid Res 2009, 50: 894-907.